Exicure, Inc. (XCUR) — 8-K Filings

8-K Filings (31)

• EXICURE Files 8-K on Financial Results, Exhibits — Mar 25, 2026
  EXICURE, INC. filed an 8-K on March 25, 2026, reporting under Item 2.02, "Results of Operations and Financial Condition," and Item 9.01, "Financial Statements a
• Exicure, Inc. Files 8-K Report — Nov 17, 2025 Risk: low
  On November 10, 2025, Exicure, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific
• Exicure, Inc. Files 8-K on Security Holder Vote — Nov 10, 2025 Risk: low
  Exicure, Inc. filed an 8-K on November 10, 2025, reporting on a matter submitted to a vote of its security holders on November 6, 2025. The filing does not prov
• Exicure, Inc. Relocates Principal Executive Offices — Sep 9, 2025 Risk: low
  Exicure, Inc. announced on September 8, 2025, a change in its principal executive offices to 400 Seaport Court, Suite 102, Redwood City, CA 94063. The company a
• Exicure, Inc. Files 8-K Report — Aug 4, 2025 Risk: medium
  On August 4, 2025, Exicure, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. The company, previously known as Ma
• Exicure Appoints New Director to Board — Jun 10, 2025 Risk: low
  Exicure, Inc. announced on June 6, 2025, a change in its board of directors. Specifically, Dr. David J. Earp has been appointed as a new Class II director, effe
• Exicure, Inc. Faces Delisting Concerns — May 28, 2025 Risk: high
  Exicure, Inc. filed an 8-K on May 28, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and other events. The ea
• Exicure, Inc. Enters Material Definitive Agreement — May 6, 2025 Risk: medium
  On April 30, 2025, Exicure, Inc. entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its counterpart
• Exicure, Inc. Appoints New Auditor — Apr 14, 2025 Risk: low
  Exicure, Inc. filed an 8-K on April 14, 2025, to report changes in its certifying accountant. The company has appointed BDO USA, LLP as its new independent regi
• Exicure, Inc. Relocates HQ, Reports Officer/Director Changes — Mar 5, 2025 Risk: medium
  Exicure, Inc. announced on February 27, 2025, a change in its principal executive offices to 2430 N. Halsted St., Chicago, IL 60614. This filing also indicates
• Exicure, Inc. Files 8-K: Material Agreements & Equity Sales — Feb 21, 2025 Risk: medium
  Exicure, Inc. entered into a Material Definitive Agreement on February 14, 2025. The company also reported on Unregistered Sales of Equity Securities and Other
• Exicure, Inc. Files 8-K for Material Definitive Agreement — Jan 22, 2025 Risk: medium
  On January 19, 2025, Exicure, Inc. entered into a Material Definitive Agreement. The filing also includes financial statements and exhibits. Exicure, Inc. is in
• Exicure, Inc. Announces Director Departure and Election — Jan 6, 2025 Risk: medium
  On January 1, 2025, Exicure, Inc. filed an 8-K report detailing the departure of Director Dr. David R. Walt and the election of Dr. Robert J. T. H. Davies as a
• Exicure, Inc. Files 8-K on Officer/Director Changes & More — Dec 20, 2024 Risk: medium
  Exicure, Inc. filed an 8-K on December 20, 2024, reporting on events that occurred on December 17, 2024. The filing covers the departure of directors or certain
• Exicure, Inc. Files 8-K Report — Dec 17, 2024 Risk: low
  On December 17, 2024, Exicure, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions, financial figur
• Exicure, Inc. Files 8-K: Material Agreement, Delisting Notice — Dec 11, 2024 Risk: high
  Exicure, Inc. filed an 8-K on December 11, 2024, reporting a material definitive agreement. The filing also indicates a notice of delisting or failure to meet c
• Exicure Appoints New Director, Announces Executive Compensation Changes — Nov 25, 2024 Risk: medium
  On November 21, 2024, Exicure, Inc. filed an 8-K report detailing the departure of Director Dr. David E. Bearss and the appointment of Dr. Richard A. Miller as
• Exicure, Inc. Files 8-K — Nov 20, 2024 Risk: low
  Exicure, Inc. filed an 8-K on November 20, 2024, reporting other events. The company, previously known as Max-1 Acquisition Corp, is incorporated in Delaware an
• Exicure, Inc. Files 8-K: Material Agreement, Acquisition, Officer Changes — Sep 30, 2024 Risk: medium
  Exicure, Inc. announced on September 30, 2024, that it entered into a Material Definitive Agreement. The company also reported the completion of an acquisition
• Exicure, Inc. Files 8-K: Financial Statements and Exhibits — Sep 18, 2024 Risk: low
  On September 18, 2024, Exicure, Inc. filed an 8-K report. The filing primarily serves as a notification of the company's financial statements and exhibits. No s
• Exicure, Inc. Files 8-K for Material Agreement — Sep 13, 2024 Risk: medium
  On September 12, 2024, Exicure, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities and othe
• Exicure, Inc. Files 8-K with Key Corporate Updates — Aug 26, 2024 Risk: medium
  Exicure, Inc. filed an 8-K on August 26, 2024, reporting events that occurred on August 20, 2024. The filing indicates material modifications to the rights of s
• Exicure, Inc. Files 8-K: Other Events & Financials — Aug 19, 2024 Risk: low
  Exicure, Inc. filed an 8-K on August 19, 2024, reporting on other events and financial statements. The company, formerly known as Max-1 Acquisition Corp, is inc
• Exicure, Inc. Files 8-K for Other Events — Aug 15, 2024 Risk: low
  Exicure, Inc. filed an 8-K on August 15, 2024, to report other events and financial statements. The company, formerly known as Max-1 Acquisition Corp, is incorp
• Exicure Sells Gene Editing Business — Aug 1, 2024 Risk: medium
  On July 31, 2024, Exicure, Inc. (XCUR) announced a strategic shift, entering into a definitive agreement to sell its gene editing business to a third party. Thi
• Exicure, Inc. Files 8-K on Shareholder Votes and Exhibits — Jul 1, 2024 Risk: low
  Exicure, Inc. filed an 8-K on June 28, 2024, reporting on matters submitted to a vote of security holders and financial statements/exhibits. The filing does not
• Exicure Faces Delisting Concerns — Jun 25, 2024 Risk: high
  Exicure, Inc. filed an 8-K on June 25, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company's common stock was prev
• Exicure, Inc. Faces Delisting Concerns — May 23, 2024 Risk: high
  Exicure, Inc. filed an 8-K on May 23, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company's principal executive off
• Exicure, Inc. Faces Delisting Concerns — Apr 22, 2024 Risk: high
  Exicure, Inc. filed an 8-K on April 22, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event reported was on
• EXICURE Confirms Emerging Growth Company Status — Feb 5, 2024
  EXICURE, INC. filed an 8-K on February 5, 2024, to disclose that it is an "emerging growth company" as defined by the SEC. This status allows the company to tak
• Exicure (XCUR) to be Delisted from Nasdaq — Jan 16, 2024
  Exicure, Inc. (XCUR) announced on January 16, 2024, that The Nasdaq Stock Market LLC informed them on January 11, 2024, of its decision to delist the company's

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX